It’s what scholars dream about: getting to work
with the latest technology and leading researchers in the industry to
develop a scientific breakthrough.
Gagliano is part of the physics department team at Wake Forest developing a technology called Next-Gen Lab-on-Bead. The tool uses next-generation genetic sequencing to make the drug development process thousands of times faster, much like a Google search.
“I usually just tell people I am trying to find new drugs for cancer,” he said.
The National Institutes of Health (NIH) has awarded the team a $700,000 grant to bring Next-Gen Lab-on-Bead to market. The NIH awarded the funding through its Small Business Innovation Research program, and Wake Forest will share the funds with partner NanoMedica, a Winston-Salem company that has licensed the patent for Next-Gen Lab-on-Bead. Read More.
